4//SEC Filing
Moran Kevin Patrick 4
Accession 0001209191-23-043990
CIK 0001347178other
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 4:30 PM ET
Size
7.4 KB
Accession
0001209191-23-043990
Insider Transaction Report
Form 4
Moran Kevin Patrick
SVP, CFO & Treasurer
Transactions
- Sale
Common Stock
2023-07-28$6.30/sh−412$2,596→ 122,514 total - Sale
Common Stock
2023-07-28$6.30/sh−1,800$11,349→ 120,714 total
Holdings
- 635(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]Represents shares of the Issuer's common stock sold to satisfy tax obligations relating to the acquisition of shares of the Issuer's common stock in connection with the settlement of the vested portion of RSUs. Such sale was executed pursuant to an irrevocable election made by the Reporting Person during an open trading window under a program approved by the Compensation Committee of the Issuer's Board of Directors.
Documents
Issuer
Vanda Pharmaceuticals Inc.
CIK 0001347178
Entity typeother
Related Parties
1- filerCIK 0001806596
Filing Metadata
- Form type
- 4
- Filed
- Jul 31, 8:00 PM ET
- Accepted
- Aug 1, 4:30 PM ET
- Size
- 7.4 KB